ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000208.1|Chelocardin_2 # 452 # 1399 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0000208.1|Chelocardin_2 	452	1399	+	Loose	600	29.261	rgt1438	37.5	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGCCACTCCGACAAGCCGCCACCGCAGCCGGCCTGATCACCGGATATTTCGCCGACACCTGGTTCGGGGACCCCCGCCGGGGGCATCCGGTGGCCGGGTTCGGCACCGTCGCGGCCGCACTGGAACAGCGCTGGTGGGCCGACTCGAAGAGCCGTGGCGCTGTGTACGCCGGGGCCTGCGCGGGTGCGGCGACCGGGCTGGGGCTGGCCGCGCAGATGGCGACCCGGCGGCGTCCGCTCGCCCGGTTCGCGCTGACCGCGGCGGCGACCTGGGTGGTGCTCGGCGGGCGCGGGCTGGCCGCCGAGGGCCGGGAAATGGCGCGGCTGCTCGAATCGGGCGAAGTGCCCGCCGCACGGGAGCGGCTCGGCCACCTCTGTGCCCGCGACGCGACCGGCCTCGACGCCGCGGAGCTGAGCCGGGCGGCCACGGAATCGATCGCGGAGAACACGTCGGACGCGGTGGTGGCGCCGCTGCTGTGGGGCGCGGTCGCCGGGATCCCCGGGCTGCTCGGGTACCGCGCGGTCAACACGCTCGACGCGATGGTCGGCTACCGCTCGCCGCGGCACCGGAACTTCGGCTGGTTCGCCGCCCGTACCGACGATCTGGTCAACCTCGTGCCCTCCCGGGCCGGCGCGCTGCTGACCACGGCCGTGGCGCCGCTGGCGGGCGGCCGGTCCCGGACCGCGTGGCGGACCTGGCGGCGGGACGGATCCGCGCACCCGAGCCCGAACGCCGGACAGGTCGAGGCTGCCTTCGCCGGAGCGCTGGGAATCCGCCTCGGTGGTACGAACAGTTATCACGGTGAGACGGAGCGTCGCGGCACCCTCGGCGACGGCCGTCCGCCGGGACCGGCGGATCTGCGGAGGGCGGTGCGGTTGTCCCGCGTTGTGGGAGCAGCGGCGCTCGTCGTGGCTGCGGCAGGGGTGTTCGGGGTGAGGGCGCGATGA	MPLRQAATAAGLITGYFADTWFGDPRRGHPVAGFGTVAAALEQRWWADSKSRGAVYAGACAGAATGLGLAAQMATRRRPLARFALTAAATWVVLGGRGLAAEGREMARLLESGEVPAARERLGHLCARDATGLDAAELSRAATESIAENTSDAVVAPLLWGAVAGIPGLLGYRAVNTLDAMVGYRSPRHRNFGWFAARTDDLVNLVPSRAGALLTTAVAPLAGGRSRTAWRTWRRDGSAHPSPNAGQVEAAFAGALGIRLGGTNSYHGETERRGTLGDGRPPGPADLRRAVRLSRVVGAAALVVAAAGVFGVRAR	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	76.64	gnl|BL_ORD_ID|116|hsp_num:0	134			1014	1176	rifampin; rifaximin; rifabutin; rifapentine
BGC0000208.1|Chelocardin_4 # 3079 # 4377 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.687	BGC0000208.1|Chelocardin_4 	3079	4377	+	Loose	1800	25.7942	MexD	32.08	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACAGGACCAAGCGATGCCCATCGTGTCGTGATTACCGGGATTGGGGTGGTCGCCCCGGGCGACCGTGGTACCAAGCAGTTCTGGGAGCTGATCACGGCGGGCCGTACGGCCACCCGGCCGATCTCGTTGTTCGACGCGAGTTCCTTCCGGTCGAGGGTGGCCGCCGAGTGCAACTTCGATCCGATCGCCGCCGGGCTGAGCCAGCGGCAGATCCGGAAATGGGACCGCACCACGCAGTTCTGCGTGGTGGCGGCAAGGGAGGCGGTGGCCGACAGCGGGATGCTCGGGGAGCAGGATCCCCTGCGTACGGGGGTGGCGATCGGCACCGCCTGCGGCATGACCCAGAGCCTGGACCGCGAGTACGCGGTGGTCAGCGACGAGGGCAGCAGCTGGCTGGTCGACCCGGATTACGGGGTGCCCCAGCTCTACGACTACTTCCTGCCGTCCTCGATGGCCACCGAGATCGCGTGGCTGGTGGAGGCGGAAGGACCGGTGGGGCTGGTTTCCACCGGATGCACGTCGGGGGTCGACGTGATCGGGCACGCCGCCGACCTGATCCGCGACGGCGAGGCCGACATCATGGTCGCCGGTGCCTCCGAGGCGCCGATCTCGCCGATCACGGTGGCCTGCTTCGACGCGATCAAGGCCACCACGGCACGCAACCACGAACCCGAGTCGGCTTCCAGGCCGTTCGACCAGACCCGCAGCGGGTTCGTGCTCGGCGAGGGCGCGGCCGTCTTCGTGCTGGAGGAGCTGAGGCACGCCAAGCGGCGGGGCGCGCACATCTACGCCGAAATCGTCGGGTACGCGTCCCGGTGCAACGCCTACAGCATGACCGGGTTGCGTCCGGACGGCCGCGAGATGGCCGACGCGATCGACGGGGCGTTGAACCAGGCCAGGATCGACCCGTCCCGGATCGGCTACGTCAACGCCCACGGGTCGTCGACCAGGCAGAACGATCGGCACGAGACCGCGGCCATCAAGACCAGCCTCGGAGCGCACGCCTATCAGGTGCCGGTCAGCTCGATCAAGTCGATGGTCGGGCATTCGCTCGGCGCGATCGGCTCGCTGGAGGTCGCGGCCTGCGCGCTGACCATCGAGCATTCGGTGATCCCGCCGACGGCGAATCTGCACGTGCCCGACCCGGAGTGCGACCTGGACTACGTGCCACTGGTGGCGCGGGAACAGGAGGTCGACGTGGTGCTCAGCGTCGCGAGCGGGTTCGGCGGTTTCCAGAGTGCCATCCTGCTGACCGGCCCGGACGGCAGAACCGGGAAGCGGGTAACGCAGCGATGA	MTGPSDAHRVVITGIGVVAPGDRGTKQFWELITAGRTATRPISLFDASSFRSRVAAECNFDPIAAGLSQRQIRKWDRTTQFCVVAAREAVADSGMLGEQDPLRTGVAIGTACGMTQSLDREYAVVSDEGSSWLVDPDYGVPQLYDYFLPSSMATEIAWLVEAEGPVGLVSTGCTSGVDVIGHAADLIRDGEADIMVAGASEAPISPITVACFDAIKATTARNHEPESASRPFDQTRSGFVLGEGAAVFVLEELRHAKRRGAHIYAEIVGYASRCNAYSMTGLRPDGREMADAIDGALNQARIDPSRIGYVNAHGSSTRQNDRHETAAIKTSLGAHAYQVPVSSIKSMVGHSLGAIGSLEVAACALTIEHSVIPPTANLHVPDPECDLDYVPLVAREQEVDVVLSVASGFGGFQSAILLTGPDGRTGKRVTQR	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	41.42	gnl|BL_ORD_ID|1485|hsp_num:0	1523			2358	2508	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000208.1|Chelocardin_5 # 4374 # 5630 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000208.1|Chelocardin_5 	4374	5630	+	Loose	750	102.064	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	29.0	3003463	protein variant model	G387D, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGTGGAGACAGAACCGGCGCCGGTGCCCGGCCGCAGCACGGTACGGCCGGTGGTGACCGGGTTGGGCGTGATCGCGCCCAACGGTATGGGCACCGAGGCCTACTGGGCGGCGACCCTTCGTGGCGACAGCGGACTGCGGCGGATCACCCGGTTCGACCCGGACGGCTACCCGGCCCGGATCGCGGGCGAGGTCAGCTTCGACCCGGCCGGGCGGCTGCCCGACCGGCTGTTGCCGCAGACCGACCACATGACCCGGCTCGCGCTGATCGCCGCGGAGGAGGCACTCGCCGACGCGGGTGCCGATCCGCGGAACCTGCCCGACTACGCGACCGGGGTCATGACCGCGGCCTCGGGCGGCGGATTCGAGTTCGGGCAACGGGAACTGCAGGAGCTGTGGAGCAAAGGCGGCTCCTACGTCAGCGCGTACCAGTCCTTCGCCTGGTTCTACCCGGTGAACACCGGGCAGATCTCGATCCGGCACGGGATGCGCGGCTCCAGCGGCACGCTCGTGTCCGAACAGGCCGGTGGGCTGGACGCGGTCGCCAAGGCCCGCAGGCACGTGCGCGACGGAACACCGCTGATGGTGACCGGCGGCATCGACGGATCGCTGTGCCCGTGGTCCTGGCTGTGCATGCTGCGCTCCGGCCGGTTGAGCACGGCGAGTGATCCTCAGCGCGCCTATCTGCCCTTCGATACCGAGGCTTCCGGGATGGTGCCGGGTGAGGGTGGCGCGTTGCTGGTGATCGAGGATCCCGCCGCGGCACAACGGCGTGGCGTGGACCGGATCTATGGGCAGATCGCCGGCTATTGCGCGACATTCGACCCCGGCCCGGGTTCACGTCGTCCGCCCGGCCTGCGCCGGGCGGTCGAGCAGGCGCTGGCCGAAGCACGGCTGCATCCGTCCGAAGTGGACGTGGTGTTCGCCGACGCCGCCGGTCTGCCCGACCTCGACCGGGCCGAGATCGAAGTGCTGGTCCGGATCTTCGGCGCGCGGGCCGTCCCGGTCACTGCACCCAAGACGATGACCGGCCGGCTGCTGGCCGGTGGAAGCTCGCTGGACCTGGCCACGGCGTTGCTCTCCCTGCGGGACAAGGTCATTCCGCCCACCGTCCACATAGGAAAGTTCGGTTACCGGGACGAGATCGACCTGGTTCGCGACAGCCCCCGGCAGGCGCCGCTGTCGACTGCGCTGGTGCTGGCCCGAGGGTATGGCGGGTTCAACTCCGCGATGGTGCTTCGCGGTGCCACCTGA	MSVETEPAPVPGRSTVRPVVTGLGVIAPNGMGTEAYWAATLRGDSGLRRITRFDPDGYPARIAGEVSFDPAGRLPDRLLPQTDHMTRLALIAAEEALADAGADPRNLPDYATGVMTAASGGGFEFGQRELQELWSKGGSYVSAYQSFAWFYPVNTGQISIRHGMRGSSGTLVSEQAGGLDAVAKARRHVRDGTPLMVTGGIDGSLCPWSWLCMLRSGRLSTASDPQRAYLPFDTEASGMVPGEGGALLVIEDPAAAQRRGVDRIYGQIAGYCATFDPGPGSRRPPGLRRAVEQALAEARLHPSEVDVVFADAAGLPDLDRAEIEVLVRIFGARAVPVTAPKTMTGRLLAGGSSLDLATALLSLRDKVIPPTVHIGKFGYRDEIDLVRDSPRQAPLSTALVLARGYGGFNSAMVLRGAT	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.48	gnl|BL_ORD_ID|1968|hsp_num:0	1943			87	1239	isoniazid
BGC0000208.1|Chelocardin_6 # 5655 # 5921 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.670	BGC0000208.1|Chelocardin_6 	5655	5921	+	Loose	1000	25.7942	Clostridium perfringens mprF	37.84	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGCAGAGTTCACGATCGCCGAGCTGGTGCGGCTGCTGCGCGAATGCGCCGGAGAGGAGGAAGGCGTGGACCTCGACGGCGAGGTCGGGGACCTGCCGTTCGACGAACTCGGCTACGACTCCCTCGCGCTGTTCAACACCATCGGGCGGATCGAGCGTGAGTACACTGTGGACCTCCCCGAGGACGTAGTGTGGCAGGCGACCACGCCGGGAGCGCTGGTCGATCTGGTCAACAGCAGTCGCACGTCGCCCGCTGCCGCCGACTGA	MAEFTIAELVRLLRECAGEEEGVDLDGEVGDLPFDELGYDSLALFNTIGRIEREYTVDLPEDVVWQATTPGALVDLVNSSRTSPAAAD	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	15.47	gnl|BL_ORD_ID|2058|hsp_num:0	2282			1026	1119	defensin
BGC0000208.1|Chelocardin_7 # 5963 # 6871 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.678	BGC0000208.1|Chelocardin_7 	5963	6871	-	Loose	700	27.7202	CMY-49	26.26	3002060	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGTCACACCCCGAGGCCGAGCAGACGCAGGCCAGTATCGTCGTGGACGCGCCCGCCGAGATCACCTACGCCATGCTGGTCGACGTCGCGAACTGGCCGCTGCTCTACCCGTGGATCGCGCACACCGAGTTCGTGGAGCGAGCGCCGACCGAGGATCTGGTGCAGTTCTGGGCGGTCAACCCGCTGGGCAGGATCCGGATCTGGACCTCCCGCCGGTACCTGGACGCGAGCGCGCTGCGGATGGACATCGAGCAGCAGGGCTCGGTCGGCCCGATCACCGGGCTGACCGGGTCGTGGACCTTCAAACCGCTGCCGGGTGACCGGTGCCTGGTGGAGTCCCGGCACGCCTTCCACGCCGCCACGCCGGAGGATCGCGCGGCCGGGGTCACCGAACTGAACCGGCACGGCAAGCTGCAGATGGAGACCCTCAAGAGCCGGGTCGAGAACCGTACCCGGCTCGCGGAGCTGACCTGGTCGTTCGAGGATTCGCTGGTGATCGAGAGCGAACTCGGGCAGGTCTACCGCGCGCTGCGAGACGTCGGGTCCTGGCCTGCACATCTGCCCTGCCTCACCGCGCTTGAGGTCACCGAGGACGAGAACGACGTGCAGTTCTACGACGTGCGCACGCAAGATGCGGACGAGCCGAGCCGGTTCGTCCGCATCTGCTTGCCGGACAAGGGAATCGCGTACAAGCAGCTGACCGTGACCGCACCGGTGGACCTGCACCTCGGCCGGTGGACCCTGACCGAGACGCCTGCGGGAGTCGCCGTCACGTCCGCGCATACGGTGCTGGTGAACCCGTCGGCAGCCGAACAGCTCCCTGAATTGCGTGACCGGCTGCACAAGACGTCGAGTGCGGACAGCCTGGCCGAGCTGCAGCTGGTCAAGCGGCTGGCAGAAACCCGCTGA	MSHPEAEQTQASIVVDAPAEITYAMLVDVANWPLLYPWIAHTEFVERAPTEDLVQFWAVNPLGRIRIWTSRRYLDASALRMDIEQQGSVGPITGLTGSWTFKPLPGDRCLVESRHAFHAATPEDRAAGVTELNRHGKLQMETLKSRVENRTRLAELTWSFEDSLVIESELGQVYRALRDVGSWPAHLPCLTALEVTEDENDVQFYDVRTQDADEPSRFVRICLPDKGIAYKQLTVTAPVDLHLGRWTLTETPAGVAVTSAHTVLVNPSAAEQLPELRDRLHKTSSADSLAELQLVKRLAETR	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEAYGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALHTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	79.27	gnl|BL_ORD_ID|1383|hsp_num:0	1501			759	1029	
BGC0000208.1|Chelocardin_8 # 6960 # 7991 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.648	BGC0000208.1|Chelocardin_8 	6960	7991	-	Loose	850	26.9498	tet(38)	26.47	3000565	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGAGACGGAACCGACCACAGTGACCGCGAAGAAGCTGCACGAAATCATGCGCGGCTATGTGAAAACGGCACTGCTGCGCACGGCGATCGAGCTGAACATCTTCGACGGCATCGGCGACCGTACCGTCGACGCCGACGGCCTGGCGCGTGCGCTCGGGGTGGACGCCAGAGGACTGCGCATCACGCTGGACTCGTTGGCAGCCATCGGGTTGCTGCGCACGGTCGACGGGAAGTACGCGTTGCCGGTGGACGGCGACAAGTTCCTGCTCAGCTCCAGCCCGACCTTCTTCGGGCCGTCGTTGAAGCTGGGCGCCAGCGACTGGGAATGGGACGCGCAGAAGCGGCTCACCGAGGCGGTGCGCAAGGGCGGCGCCGTGATGGACAGCCACGCCCTGACCCCGGAATTCGACTACTGGGAGGACTTCGCGGAGAACACCACCTGGTTCAACAACGGTGCGGCCGAACTGATGGCGGAGCAGTTGCTGCCCTGGGCCAAGGACCGCGACAGCGTCGACGTGCTCGACGTGGCCTGCAGCCACGGCTACTACGGCGTCAACCTGGCCAAGGCCGAGCCGAAGGCCCGGGTCTGGGGCGTGGACTGGCCGAACGTACTGCCGATCACCGCGAAGAACTACGAGCGCAACGGGATCAGCGACCGGTTCGAGGGAATCCCGGGCGACATGTTCAGCGTCCCGCTCGGCGGTCCCTACGACGTCGTGATGATCACCAATGTGCTGCACCATTTCTCGGCGGACACGTCGACGAACCTGTTGCGCAGGCTGTTCGACGTGCTCAAGCCGGGTGGGCGGATCGCGGTCACCGGGCACACCTTCGTCGAGGGCGAGCGCCCGGAGGACAAGCCGCTGCCGTACCTGTTCTCGCAGATCATGCTGGTGATGACCGACGAAGGCGAGACACACTCGACCAAGACCTACGAGCGCATGTTCACCGACGCCGGTTTCGTCAACCCGCAGATTTTCACCGCGGAGAAGGCCATGCACACGGTATTCACCGCAGACAAGGCCTGA	MTETEPTTVTAKKLHEIMRGYVKTALLRTAIELNIFDGIGDRTVDADGLARALGVDARGLRITLDSLAAIGLLRTVDGKYALPVDGDKFLLSSSPTFFGPSLKLGASDWEWDAQKRLTEAVRKGGAVMDSHALTPEFDYWEDFAENTTWFNNGAAELMAEQLLPWAKDRDSVDVLDVACSHGYYGVNLAKAEPKARVWGVDWPNVLPITAKNYERNGISDRFEGIPGDMFSVPLGGPYDVVMITNVLHHFSADTSTNLLRRLFDVLKPGGRIAVTGHTFVEGERPEDKPLPYLFSQIMLVMTDEGETHSTKTYERMFTDAGFVNPQIFTAEKAMHTVFTADKA	MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK	76.22	gnl|BL_ORD_ID|1791|hsp_num:0	1835			726	909	tetracycline
BGC0000208.1|Chelocardin_9 # 8155 # 9354 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.724	BGC0000208.1|Chelocardin_9 	8155	9354	+	Loose	700	31.187	oleI	24.5	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGCTGTTGCTGGTCACTTGGAATGCGCCGGCTCACCTGTTCGCGATGGTGCCCCTCGGCTGGGCCGCGCAAGTAGCCGGGCACGAGGTTCGCGTCGCGGCTCCGCCCTCCTGTACCGAGGCGATCGGCCGTACCGGCCTGACCGCCGTACCCGTCGGCACGCAGCGTCCGGCCGCGCCGTCCGGGCCTCCGCCGGGAGCGCCCAGCGGTCGCTGGCCGGTCGACTGGGCGGTGCATCCCGAACTGCTCGACGACAGCCGGCACGAGCTTCTGCGTTCGCTGGCCGCGCGCCAGTTCGCCGCCGCCGAGCCGATGCTGGACGACTTGATCGAGTTCGCACGCTGGTGGTCGCCGGACGTCGTGGTGTACGACCCGACCAGCCTGGCCGGCGAAGTGGCGGCCACCGTGCTCGGCGTGCCCGCCTTCGCCTGTTCCTGGGGCCGCGCGGCGGCCGTCCGGATCGAGCGGGGTCTGGGCTCCGAGCCGCTGCTTGGCTACGCGCGGCTGTTTGAACGGTTCGGGTGCCAGGCCCCGCAGGGACCCGCCTCCTGGTTCGACCCGTTCCCCGCCGGTCTGTGGCTGGCTGAACCGGATTTGCCGCGGCAGGCGATGCGCTTCGTGCCTGGAACCGGCGGCGACGCCGGTTCGCTACCCGGCTGGCTCCGGGAACACTCGGCTCGGCCGAGGATCTGCGTCACCAGCGCGGAACCCGGTGGTCTGTTGCGGCCGGAAGCCGTACGGGCATTCTACCGGCACGCGCTCACCGTACTGTCCGATGTGGACGCTGAGGTCGTGGTGCCCGCGGGTCCGGCGGCCCGCACGCTGCTGGCCGAGATTCCGCACACCGCGCGGATCGTCGACCCGGTGGCCGCGCATCTGCTCGTCCCGGCCTGCCGGCTCACCGTGCACCAGGGTGACGGGCTGTCCACTTTGGCCGGTCTGAATTCGGGGGTTCCCCAGTACGTCCTGGCGCCACGTCCGGAGCAGGAGCTGGTGGGGCACCAGCTGCACCGAGCCGGTGCGGGCGGCTACCGGAGCCTGTCCGAACCCGTGGACGTTCCGGCCGAACGTGCGGTGCTGGATGCCTTGCTGGCACCGGAAAGCGGGGGAGCGGCGGCCCGCAAGCTGCAGGAGGAAACGCTGGCACTCCCGCTCCCGTCCGCCGTGCTCGGCCGGATCGAGTCCGCCACCCGCTGA	MRLLLVTWNAPAHLFAMVPLGWAAQVAGHEVRVAAPPSCTEAIGRTGLTAVPVGTQRPAAPSGPPPGAPSGRWPVDWAVHPELLDDSRHELLRSLAARQFAAAEPMLDDLIEFARWWSPDVVVYDPTSLAGEVAATVLGVPAFACSWGRAAAVRIERGLGSEPLLGYARLFERFGCQAPQGPASWFDPFPAGLWLAEPDLPRQAMRFVPGTGGDAGSLPGWLREHSARPRICVTSAEPGGLLRPEAVRAFYRHALTVLSDVDAEVVVPAGPAARTLLAEIPHTARIVDPVAAHLLVPACRLTVHQGDGLSTLAGLNSGVPQYVLAPRPEQELVGHQLHRAGAGGYRSLSEPVDVPAERAVLDALLAPESGGAAARKLQEETLALPLPSAVLGRIESATR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	94.10	gnl|BL_ORD_ID|1684|hsp_num:0	1824			51	1188	oleandomycin
BGC0000208.1|Chelocardin_10 # 9408 # 9545 # -1 # ID=1_10;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.551	BGC0000208.1|Chelocardin_10 	9408	9545	-	Loose	500	21.9422	Vibrio cholerae varG	33.33	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	TTGCTGATGATCTCGACAATCACCAGCTCTAGCCGGAGCCTCGTTGCCTATCCACACCACCACGCCGATCACACCCAAACCGTGATCAACACCACCCACCAGACCTTAAGTTCCTGGCATTGGACTCTGAGTCCGTGA	MLMISTITSSSRSLVAYPHHHADHTQTVINTTHQTLSSWHWTLSP	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	11.54	gnl|BL_ORD_ID|2428|hsp_num:0	2842			408	471	meropenem
BGC0000208.1|Chelocardin_11 # 9559 # 11094 # 1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.692	BGC0000208.1|Chelocardin_11 	9559	11094	+	Loose	1190	28.4906	novA	56.52	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGTCCGTTCATGGTGTCATGCCCTCGGGCTGGTCCTCGCCGGTGGGTCGGTTGTTGTCACAGGCCGGGCTGGGGTTGCTGTCGTGGGTCGTCCCGCCCGCGCTGGTTGATGAGGCGCTGGCCGTCGCCGGCCGGGACGAACGGCGGTTCCGGGCACTGCCGTCGCGGTTGGGCGTGTACTTCGTGCTCGCGTTGTGCCTGCTGCGCACCAAGTCCGGCAACGCGACGATCAGGGCGATGTTCTCGCAGGAGAGTCTGCCCCGGTTGTCCGTGCTGGGCTGGTGGCCGCCGGCCAGCACGGCGCTGACCAAGCTGCGGGACCGGATCGGCGTGGTGCCCTTCCAGTTGTTGTTCGGCGCGCTGGCGCGGGCGGCGCCTACCCGGAACAGGCCGTGGTCGCACGCGTTCGGGCTGGAGGTGTGTGCCTGGGACGGCACCGAGGTCGAGCCGGCCGACACCGCGGCCAACCGTGAACACTTCCCGCCCCATCACCGCACAGGCGTGGCCCGCGGGCCGTCCAAGATCCGGGTGCTGGTGCTGCTGTCGTGTGGCAGCCGCCGTCTGCTCGGCGCGGTCACCGGCCCGCTGAGCCAGGGCGAGCCCACCCTGGCCTATCAGCTGCTGCCCCGGCTGCACGACCGGATGCTGCTGCTGGCCGACCGCTGCTTCCTCGGCTATCCACTGTGGACCGCGGCGCGGGAACGGGGCGCGCATCTGCTGTGGCGGGCCAAGCAGAACACCCCGAAGCTGCCCGTGCAGCACGCGTTGCCGGACGAGTCCTGGCTGTCCACCCTCCACGCCCCGGCCGACGCCCGCCGCTGGGCGCGCAACGTGCGCCGCAACAAGCAACGCGGGCACCGCCCGCCCACGCCCCGCCCGATCAACGGCATCGTCGTCCGGGTGGTCGAAGCACTGATCACCGTCACCGTCGACGGCGTCACCCGCACCGAGAAATACCGGCTGGTCACCAGCCTGCTCGACCCCGCACACGCACCCGCCGGCCAGCTCGTCGCCCTCTACGCCCGCCGCTGGACCGCCGAAACCGGCATCAAAGAGATCAAAACCACGCTGCTGGCCAAGCGGCCCCTGCGCGGCCACACCCCGATCCGCGCCCAGCAGGAACTCTGGGCCACCCTGATCGTCTACCAGGCCATCCGGCTGCTGATCAGCCACGCAGCGCTCACCCAGAACCTCGACCCGTCCCGGATCTCCTTCACCTCCGCCCGCGACGCCGCCGAACACGCGATCACTACCACACCCGCCGACACATCCCGACACCTCCAATGGGTGGCCCAGGACTTATGCCGACAGCTGATCACCGTCCACACCCACCACCGCGTCTACCCCCGAGCACTCAAACGCACCACCACGCGCTACCCCCACCGCAGCAAAACCCCGCAACCGACCAGCACCAAAGCCAGCTACCAGGTCCACATCCTGCCCACAGCAGAAACAACACCACCCACCACAACCAAACCAACACCACACCAACCCAGAACCGACCTAAGTTCCTGGCATTGGACTCAGAGTCCGTGA	MSVHGVMPSGWSSPVGRLLSQAGLGLLSWVVPPALVDEALAVAGRDERRFRALPSRLGVYFVLALCLLRTKSGNATIRAMFSQESLPRLSVLGWWPPASTALTKLRDRIGVVPFQLLFGALARAAPTRNRPWSHAFGLEVCAWDGTEVEPADTAANREHFPPHHRTGVARGPSKIRVLVLLSCGSRRLLGAVTGPLSQGEPTLAYQLLPRLHDRMLLLADRCFLGYPLWTAARERGAHLLWRAKQNTPKLPVQHALPDESWLSTLHAPADARRWARNVRRNKQRGHRPPTPRPINGIVVRVVEALITVTVDGVTRTEKYRLVTSLLDPAHAPAGQLVALYARRWTAETGIKEIKTTLLAKRPLRGHTPIRAQQELWATLIVYQAIRLLISHAALTQNLDPSRISFTSARDAAEHAITTTPADTSRHLQWVAQDLCRQLITVHTHHRVYPRALKRTTTRYPHRSKTPQPTSTKASYQVHILPTAETTPPTTTKPTPHQPRTDLSSWHWTQSP	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	83.09	gnl|BL_ORD_ID|1112|hsp_num:0	1210			1173	1239	novobiocin
BGC0000208.1|Chelocardin_12 # 11114 # 11233 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.750	BGC0000208.1|Chelocardin_12 	11114	11233	-	Loose	1900	21.9422	MuxC	34.38	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGAGGTCCCCCGGCATGGGGGATCTCGTCCGGGCCGCCGCCAGGGGAACCCCCACTCCTGGCGGCGGCCTGTTCGTGGCCTCCGGGCAGGCCGTGGCGCGCCTCGACCAACCGTGA	MRRSPGMGDLVRAAARGTPTPGGGLFVASGQAVARLDQP	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	3.76	gnl|BL_ORD_ID|2367|hsp_num:0	2720			1869	1965	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000208.1|Chelocardin_13 # 11233 # 12678 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.704	BGC0000208.1|Chelocardin_13 	11233	12678	-	Loose	900	181.415	lmrB	28.47	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAGGACAATCTCGCGAGACCGGACACGGTCGGCGCCGACGAGAACCGGATCAGCCCGGCGCTGTGGGGACTGGCGTCGATCCTGATCCTCGGCGGGTTCACGTCCATGTTCACCTCGACCATCGTCAACGTCGCCCTGGACACCCTCAGCCAGAAGCTGAGCGCCCCGCTGGGCACGGTGCAGTGGACGGCGACCGGGTACCTGATGGCGCTGGCCACCGCGGTCCCGGTCAGCGGGTGGGCGTCCAAGCGCTACGGGGCGACCCGGCTGTGGCTGGGCAGCGTGGCACTGTTCACCCTGTTCTCGGCGCTGTGCGCGCTGTCGACCTCGGTGGAAATGCTGATCACCTTCCGGGTCCTGCAGGGGATCGCGGGCGGCCTGCTGGTGCCGGCCGGGCAGATCCTGCTGGTCACCGCGGCCGGGCCGAAGCGGATCGGCCGGATGCTGACCGCGGTCAGCGTGCCGATCTACCTGGCGCCCGCGGTGGGCACCACGCTGGGCAGCGTGCTGACCCAGGGCCTCGGCTGGCCGTGGCTGTTCTGGATCACCGTGCCGCTCGGCGCGCTCGGCTTCTTCGCCGGCCTGCGCTGGCTGCCGAAGGCGCCGCCGAAGGGTGCGCCCGCGCTGGATGTGCGCGGCCTGATCATCCTGGTGGCCGGCCTGCCGCTGCTGACCTACGGCGTGGCCGGGATCGGGGAGAACGGCGGCCGCACCGAGACCATCGCGGTGATCGCCGCCGTGGCCGGGGCGCTGCTGCTGGCGCTGTTCACCCTGCACGCGGTGCGCTCGAGGAATCCGCTGCTGAACCTGCGGCTGTTCAAGGACCGGGCCTTCTCCTCGGCGGCGGTCGTGATCTTCTGCATGGGGATCGCGCTGTTCGGCGCGATGATCGTGCTGCCGATCTACTTCCTCCAGGTGCGGCACGAGGATCTGGTCACCGCCGGTCTGCTGACCGCGCCGTCGGCGATCGGCACCGTGCTGGCGCTGCCGCTGGCGGGCAAGATGACCGACAAGATCGGCGGCGCCCGGGTCATCTTCGCCGGCCTGGTCGTCACCATCATCGGCACCATCCCGCTCGCGCTGGTCACCCCGCACGACAGTTACGTGTGGCTGTCGCTGGTCCAGATCGTGCGCGGCATCGGGATCGGGATGACCACCACGCCGGCGATGGCCGCCGGGCTGGCCATGATCGGCAAGGAGGACGTGCCGCACGCCACCCCGATCTTCAATGTGCTGCAACGGGTCGGCGGCTCGTTCGGGACCGCGCTGACGACGGTGCTGGTGGCCTTCCAGCTGGCCTCAGGTCCGCAGACGGACGAGGGCGCGGCCGACGCGATCGGCTACACGCACTGGTGGATCGTCGCGTGCACCGCGATCGTGCTCATCCCGTCGATGCTCCTCGTACAGGTGGAAAGCCGTCGCAGGCAGGCCGCGGCCGCCTGA	MKDNLARPDTVGADENRISPALWGLASILILGGFTSMFTSTIVNVALDTLSQKLSAPLGTVQWTATGYLMALATAVPVSGWASKRYGATRLWLGSVALFTLFSALCALSTSVEMLITFRVLQGIAGGLLVPAGQILLVTAAGPKRIGRMLTAVSVPIYLAPAVGTTLGSVLTQGLGWPWLFWITVPLGALGFFAGLRWLPKAPPKGAPALDVRGLIILVAGLPLLTYGVAGIGENGGRTETIAVIAAVAGALLLALFTLHAVRSRNPLLNLRLFKDRAFSSAAVVIFCMGIALFGAMIVLPIYFLQVRHEDLVTAGLLTAPSAIGTVLALPLAGKMTDKIGGARVIFAGLVVTIIGTIPLALVTPHDSYVWLSLVQIVRGIGIGMTTTPAMAAGLAMIGKEDVPHATPIFNVLQRVGGSFGTALTTVLVAFQLASGPQTDEGAADAIGYTHWWIVACTAIVLIPSMLLVQVESRRRQAAAA	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	100.84	gnl|BL_ORD_ID|540|hsp_num:0	592			57	1311	
BGC0000208.1|Chelocardin_14 # 12829 # 13401 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.709	BGC0000208.1|Chelocardin_14 	12829	13401	+	Loose	400	118.242	tetR	36.45	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCGGCTGAGTCCCGAAACCTTCGCGCGCGCCGCGCTGAAGCTGCTCAACAAATCCGGCCTGGAGGGGGTGAGCCTGCGCAAGCTCGGCGACGAGCTGGGCGTGCAGGGGCCCGCGCTGTACGCGCACTTCAAGAACAAGCAGGAGCTGCTCGACCTGATGGCCGAGATCATGCTCGACGAGGCGCTCGCCCCGCTGGACGCGATGACCGAGGTGGCCGACTGGCACTGGTGGCTGGCCGAACGGGCCAGGACCATCCGGCGCACCCTGCTGTCCTATCGGGACGGTGCGCTGCTGCACGCGGGATCCCGGCCGACCGCCGACGGCGCCGAAGCGATCCCGGCCCTGCTGCGGCCGTTGCGAGAGGCGGGCTTCAGCGACAAGGAAGCACTCACCGTGATCATCACCATCGGCCGCTACACGCTGGGGTGTGTGATCGACGAGCAGCGGCCGGGCGAGCCCGCCCCGCAGCCCGGCCCGGGTGCCGACGACACCTTCGAGTTCGGGCTCCAGGCGTTGCTGGCCGGACTGCGGGCCCGGCTGCCGGAACGGGTACCCGACAGCGCCGGATAA	VRLSPETFARAALKLLNKSGLEGVSLRKLGDELGVQGPALYAHFKNKQELLDLMAEIMLDEALAPLDAMTEVADWHWWLAERARTIRRTLLSYRDGALLHAGSRPTADGAEAIPALLRPLREAGFSDKEALTVIITIGRYTLGCVIDEQRPGEPAPQPGPGADDTFEFGLQALLAGLRARLPERVPDSAG	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	91.35	gnl|BL_ORD_ID|442|hsp_num:0	276			9	606	tetracycline
BGC0000208.1|Chelocardin_15 # 13415 # 14755 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.691	BGC0000208.1|Chelocardin_15 	13415	14755	-	Loose	515	30.8018	PFM-4	33.33	3007021	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PFM beta-lactamase	ATGACGAAGGCTCGGGAAGACCTGACCACCGGCTCGGCCGTGACGCTCGAACTGGCCGGCCTGCACACGGGGGTGTCCGATCCGCGGATGGACTCGATGCGGTTGCTCAGCGAGACGGCTTTCCGGTATCCGCAGGCGGTCTCGTTCGCCTCCGGCCGGCCGTATGAAGGTTTCTTCGACATCGCCAAGCTGCACCACTACCTGGACCGCTTCGTCGAGCATCTGCGTGAGCGGGGCATGCCCGAGGAACGGATCAAGAAGGCGCTGTTCCAGTACGGGCCGATCAACGGGCTGATCCGGGACATGATCGCGCGCACGCTGGAGGTGGACGAGGACATCCACGTCGCGCCGGAGGCGGTCATGGTGACCCACGGCTGCCAGGAAGCGATGATGATCGCGCTGCGCGGGCTGTTCGCCTCGCCGAGCGACGTCCTGCTGACCGTTTCGCCTTGCTACGTCGGCATCGCGGGAGCCGCGAAGATGCTCGACATCCCGATGGCCGCGGTTCCGGAGGGCGCCGAGGGTATCGATCCCGAGCAGGTCGCGGCGGTGGCCCGCGAGGTACGCGCGTCCGGTCTGCGCCCGGTGGCCTGCTACGTGACCCCGGACTTCTCCAACCCCTCGGGACACTCGCTGCCGATCGCCACCCGGCACCGGCTGCTCGAAGTCGCCGCCGAGCAGGATTTGCTGCTGCTGGAGGACAATCCGTACGGTCTGTTCGGCCGGGACGGTGCGCAGGTGCCGACGCTCAAGGCACTCGACACCCAGCGCAGGGTGATCTACCTCGGCTCCTTCGCCAAGACCGTCTTCCCCGGCGCACGCGTCGGCTACCTGGTCGCAGACCAGGAAGTGACCGGCGGCCCCGGCGCGGCCAAGCCGCTCGCCGAGGAACTCGGCAAGGTCAAGAGCATGTTCACCGTCGGCACCTCGGGCATCTCGCAAGCCCTGGTCGGCGGGGTGCTCCTGGACGCGGATTTCAGCCTGCGCACCGCGAACCGGGAGCTGGCCGACCTGTACGTGCGGCACCTGGAGGTGACGCTGAGCAGCCTCGCCGAACACTTCCCGCCGGAGCGGTTCGCCGAGCACGGCGTGCGCTGGAACGTGCCGGGCGGCGGGTTCTTCCTCTCCGTCGAGGTGCCCTTCGTCGCCGGCCTCGAAGCACTGGACCGCTCGGCCCGCGACCACGGGGTGGGCTGGGCGCCGATGAGCATGTTCTACGTCGGTGACGGCGGCGAGCACATCGTCCGGCTCGGCTTCAGCCCGCTGACCGCCGAGGAGATCCGCGAGGGGGTGCGCAGGCTGGCCGAGTTCGTCAAGGCGACCCCGCGCACCGACCGCTGA	MTKAREDLTTGSAVTLELAGLHTGVSDPRMDSMRLLSETAFRYPQAVSFASGRPYEGFFDIAKLHHYLDRFVEHLRERGMPEERIKKALFQYGPINGLIRDMIARTLEVDEDIHVAPEAVMVTHGCQEAMMIALRGLFASPSDVLLTVSPCYVGIAGAAKMLDIPMAAVPEGAEGIDPEQVAAVAREVRASGLRPVACYVTPDFSNPSGHSLPIATRHRLLEVAAEQDLLLLEDNPYGLFGRDGAQVPTLKALDTQRRVIYLGSFAKTVFPGARVGYLVADQEVTGGPGAAKPLAEELGKVKSMFTVGTSGISQALVGGVLLDADFSLRTANRELADLYVRHLEVTLSSLAEHFPPERFAEHGVRWNVPGGGFFLSVEVPFVAGLEALDRSARDHGVGWAPMSMFYVGDGGEHIVRLGFSPLTAEEIREGVRRLAEFVKATPRTDR	MKLINILSVISLACITSQVFANKSDLTLTHFKGPLYIVEDKEYVQENSMVYVGEQHITVIGATWTPATAEKLEQEIRKISPLPIKEVINTNYHTDRAGGNAYWKKLGASIVSTQMTYDLEKSQWRSIVDFTRQGMEHYPILEQSLPDQVYPGNFDLQNGHVRALYLGASHTEDGIFVYFPEERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLIRSGELPVEAIIAGHNSPIQNVELIDHYLTLLEHGEQ	176.28	gnl|BL_ORD_ID|4914|hsp_num:0	5734			141	288	
BGC0000208.1|Chelocardin_17 # 15128 # 16108 # 1 # ID=1_17;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0000208.1|Chelocardin_17 	15128	16108	+	Loose	600	55.0694	Streptomyces venezuelae rox	30.36	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	TTGGAGGAGCACGGAAAAGTCCTGATCAACGGCGACTACCGGCGGCTGCCCGGCCCGTTCAACTGCTTGCTCAGCATCCCGCAACGGCACCTGCTGAGGGAACTGCTGGCGCAGTGTCACGAGCACGCGGGCTTCCAGTACTTGTCCGGCACGAAGGTCACCGGTCTGGTCGAGGACGGTGGCCGGGTTCGGGGCGTGGTCTGTGGCGACGACCAGGTGGTGCTCGCGCACTGCGTGATCGGGGCCGACGGACGGTATTCGAAGGTGCGGCAGCTCGCCGGGATTCCCGCCGACCGGGTCGAGGGCTTCCGTCAGGACGTGTTGTGGTTCAAGCTGTCCGCCGACGGCGAGCTGCCGAGTGAGGTGCGGGTGTTCCGGGCGGGCGGCAACCCGGTGCTGGCCTACACGTCGGTACGTGACCGCGTGCAGTTCGGCTGGACGTTGCCGCACAAGGGTTATCAGCTGCTGGCGCAGCAGGGCCTCGCGCACATCAAGGAGCAGCTGCGGGCCGCCGTGCCCGGCTACGCGGACCGGATCGACGAGGAGATCACCAGCTTCCGGGACCTTTCCCTGCTGGACGTCTTCTCCGGGGGCGCCCGGCAGTGGGTGCGCGACGGTCTGCTGCTGATCGGCGACAGTGCGCACACCCACGGCCCGATCGGCGCGCAGGGGATCAACCTGGCCATCCAGGATGCTGTGGCCGCACATCCCCTGCTGCTGGAGTCGTTGCGTGCCAACGACTCCAGCGGGGCGATGCTCGGCCGGTTCGTGACCGGGCGCAAGCGGGACATCGACCGGATGAACCGGATCCAGGCCGTCCAGGGCAAGGCGATGCTGTCCGCGGGCCGGGTCTCGTCGGTGGTCCGGCCGAGGCTGGCGATGGTGGTCGCCCGCACCCCGATCTACCGCGCGATGTTGCGGCAGATCGCGTTCGGCAACACCGGGATCCGGATCCGCGCCGAGTTGTTCGCCCGCCGCTGA	MEEHGKVLINGDYRRLPGPFNCLLSIPQRHLLRELLAQCHEHAGFQYLSGTKVTGLVEDGGRVRGVVCGDDQVVLAHCVIGADGRYSKVRQLAGIPADRVEGFRQDVLWFKLSADGELPSEVRVFRAGGNPVLAYTSVRDRVQFGWTLPHKGYQLLAQQGLAHIKEQLRAAVPGYADRIDEEITSFRDLSLLDVFSGGARQWVRDGLLLIGDSAHTHGPIGAQGINLAIQDAVAAHPLLLESLRANDSSGAMLGRFVTGRKRDIDRMNRIQAVQGKAMLSAGRVSSVVRPRLAMVVARTPIYRAMLRQIAFGNTGIRIRAELFARR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	68.49	gnl|BL_ORD_ID|4833|hsp_num:0	5820			252	891	rifampin; rifaximin; rifapentine
BGC0000208.1|Chelocardin_18 # 16116 # 17141 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.698	BGC0000208.1|Chelocardin_18 	16116	17141	-	Loose	556	26.1794	erm(32)	41.38	3004592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAGGTACCGTTCTTCCCGCCGCGGTGATGCGAGTCCGCGAGCTGGCGCTCAGCGCGGCGTGCGCCGCCTCGGTCCGCGCTGCCGCCAAACTCGGCCTCGCCGACGTTCTCGACGACCAGCCCGCGACGGTGGACGAGCTGGCCAAGGCCGTGCACGCGGACCCGGGCGCCCTGCGCCGCCTGATGCGGTCGCTGACCTGTTTCGAGGTGTTCGCCGAACCGGAGCCGGACAAGTTCGTGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCGCCACGCAGCCTCAAGCACATCCTGCTGTGGGGCACCGAGCCGTGGACCTGGGAGCTGTGGCCCCATCTCGACCAGGCCGTCCGCACCGGCAAGAACGTCTTCGACGACTTGCACGGCAAGGACTTCTTCGAGTACCTGCACGAGCAGTGGCCGGAGTCGGCCGAGGTCTTCGACAAGGCCATGACCCAGTCCAGCAAGCTCTCCGCCCTGGCCATCGCCGACCGGCTCGACCTGACCGGGGCCGAGCGGCTGGCCGACATCGCGGGCGGACAGGGCAACGTCCTGGCCACCCTGCTGTCCCGCAACGAAAAGCTGAACGGGGTGCTGTTCGACCTGCCCGCGGTGGTGGCGGGCGCCGACGAGCGGCTGCGCGTGGGCGGAGCCCTGGCGGACCGGGCCGAGCTGGTGGCGGGCGACTGCCGCCGGGAGATCCCGGTGCAGGCCGACGTCTACCTGTTCAAGAACATCCTGGAGTGGGACGACGAGAGCACCGTCCTCGCGCTGCGCAACGCGGTGGCAGCCGGTCGGCCCGGCGCCCGCGTGGTGATCATCGAGAACCTGGTCGACGGCACTCCGGAGATGAAGTTCGCGACCGCGATGGACCTGTTGCTGCTGCTCAACGTGGGCGGCAAGAAGCACACCAAGGACGGCCTGCTCGGGCTGATCGGACAGGCCGGGCTGCAGGTGGACCGGGTCAGCGCGGTGAACTCCTACCTGCACATGGTCGAGACGACCATCCCGGGCTGA	MTGTVLPAAVMRVRELALSAACAASVRAAAKLGLADVLDDQPATVDELAKAVHADPGALRRLMRSLTCFEVFAEPEPDKFVHTDASRLLREDAPRSLKHILLWGTEPWTWELWPHLDQAVRTGKNVFDDLHGKDFFEYLHEQWPESAEVFDKAMTQSSKLSALAIADRLDLTGAERLADIAGGQGNVLATLLSRNEKLNGVLFDLPAVVAGADERLRVGGALADRAELVAGDCRREIPVQADVYLFKNILEWDDESTVLALRNAVAAGRPGARVVIIENLVDGTPEMKFATAMDLLLLLNVGGKKHTKDGLLGLIGQAGLQVDRVSAVNSYLHMVETTIPG	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	121.79	gnl|BL_ORD_ID|2699|hsp_num:0	3294			276	363	narbomycin; methymycin; pikromycin
BGC0000208.1|Chelocardin_19 # 17219 # 19150 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.698	BGC0000208.1|Chelocardin_19 	17219	19150	-	Loose	1000	43.8986	almE	22.07	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGCTACGCCCGAGACGACCGTCGCCCAGGACAGCACGGTGTCCGGCGACCCGTTGACCGGGATCGCGGGGTTCATCGGCGGCCCCAGGGTCGACGACCTGCTGCGTTCGGCCGCCGAACGCGCGCCCGAGCACGTGGCGATTCGTGCGGCAGCCTGCGAACTGAGCTACGCGGCGCTCGATGAGCGAGCCGGCAGACTGGCGCGGGCCGTCCACGCGCAGCTGGCCGAACCGGGGCAAGTGGTGGCGCTGGCGGGGGTACTCGACCCGGCGTTCGCCGTGTCGTTCTTCGGTATCGCCAGGTCGGGGGCGGTGCCCGCGCTGATCAACCCGCTGCTGCTGGCGGACGGACTGGTGCACGTGCTGGGCACGTCGGGCGCGGTCACGGCGATCGTGCCGCCGGAGGTGCATCGCAGGCTGGTGCCGGTGCTGGACCGGCTGCCCGAGCTGCGGCACCTCGTGCTGACCCATCGCGACGACCAGACCGAACCGTCCGGTCCGCCGACCCTGGACGAGGTCCTCGCGTCCGCACCGGACGGCGTGCTGCCCGCCACCACTTGCGACGAGAATTCCGTGGCCTGCCTGCAGTTCACGAGCGGCACCACGGGAGCAGCCAAGGCGGTCCGGCTCAGCCACCGCAACATCACCGTCAACGCGGCCCAGTCCGGACACGCGCACGGGATCACCCCGTCGTCGGTGCTGTTCAACTATCTGCCGACCTTCCACCTGATGCACCTGACGATGGCGGTCACCTTCGCCGCCACGCTGGTGCTGCACGTCGGCGACGACGTGGCTCAGGCCGTGGACGCCGCCGACAATGAGAAGGCCACGCACTTCTACAGCCTGCCCATGCGACTGTCCCGACTGGCGGTGCACCCGCGCCTGTCCACGCTGGCGGCGGACGCACTGCAGGTCATCCTGTGCGGCGGCTCGGCGCTGCCGCTGCCGTCGACCCGCGCGCTGACCGGCTGTTTCGGGGTGCCGGTCGTCCAAGGGTACGGACTTCAGGAGACGTCGCCGTCGACGCACTTCGATTCCTTGTCCTGCCCCAAAACGGGCTCGTCGGGACGGCCGGTGGCGGGCACCGGCTGCAGGATCGTCGACGTGGACTCCCGCGCGGTACTGCCGGTGGGAGAAAAGGGCGAGATCCAGGTCCGTGGCCCGCAGCTGATGCTCGGCTACCTCGGCCGCGAGCCGGGCCAGGACGTCGATCCCGACGGCTGGTTCAGCACCGGGGACGTCGGCTACGTCGACGCCGAGGGCGTGCTGTTCGTGGTCGACCGGATCAAGGACGTCTTCAAGTGCGACAACTGGCTCGTGTCGCCGACGGAGATCGAGCGGGTCGTGCTGAGTCACCCCGAGGTGGCCGACTGCGTGGTACTGGACTACCCCGACGATTTCAGCGGATCGGTCGCGTACGGGCTGGTGGTGCCCAAGGGCGCCGGGCTCAATCCGGCGCAGCTCGCCGAGTTCGTTGCCGAACGGCTGCCGTACTACGCGCACCTGCGCCACGTCGAACTGACCGACCGGATTCCCCGCTCCCCCAACGGGAAGCTGCAACGCCGTGCGCTGCGCGAACAGATCCACGCGAGAAATGCCGATGGCGCATCGGAAATCGCCCGACAGAACAGGAGCAAGACCGTGTTCACCTTCATCAACCGGTTCACCGTCACCGGCGACGCCACCGAGTTCCGGCGGCTGCTCGGCCAGATCACCGCGCACATGACCGCGCAGCCCGGCTTCCGGTCGCACCGGCTCTACCAGTCGGCCCGGGATGAAGCGGTGTTCACCGAGATCGCCGAATGGGACAGCGCCGAGGACCACCAGCGGGCGACCGCGGGCAAGGGTTTCCGCGAGCCGGTCGGCGAGGCCATGAAGCACGCGACCGCGGAGCCCGCTCCGTTCGTGCTGCGCGCCGAACACGGCGCCTAG	MATPETTVAQDSTVSGDPLTGIAGFIGGPRVDDLLRSAAERAPEHVAIRAAACELSYAALDERAGRLARAVHAQLAEPGQVVALAGVLDPAFAVSFFGIARSGAVPALINPLLLADGLVHVLGTSGAVTAIVPPEVHRRLVPVLDRLPELRHLVLTHRDDQTEPSGPPTLDEVLASAPDGVLPATTCDENSVACLQFTSGTTGAAKAVRLSHRNITVNAAQSGHAHGITPSSVLFNYLPTFHLMHLTMAVTFAATLVLHVGDDVAQAVDAADNEKATHFYSLPMRLSRLAVHPRLSTLAADALQVILCGGSALPLPSTRALTGCFGVPVVQGYGLQETSPSTHFDSLSCPKTGSSGRPVAGTGCRIVDVDSRAVLPVGEKGEIQVRGPQLMLGYLGREPGQDVDPDGWFSTGDVGYVDAEGVLFVVDRIKDVFKCDNWLVSPTEIERVVLSHPEVADCVVLDYPDDFSGSVAYGLVVPKGAGLNPAQLAEFVAERLPYYAHLRHVELTDRIPRSPNGKLQRRALREQIHARNADGASEIARQNRSKTVFTFINRFTVTGDATEFRRLLGQITAHMTAQPGFRSHRLYQSARDEAVFTEIAEWDSAEDHQRATAGKGFREPVGEAMKHATAEPAPFVLRAEHGA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	115.65	gnl|BL_ORD_ID|4935|hsp_num:0	5928			573	1659	colistin A; colistin B
BGC0000208.1|Chelocardin_20 # 19176 # 19628 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.702	BGC0000208.1|Chelocardin_20 	19176	19628	-	Loose	525	23.8682	myrA	36.36	3001300	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTCACAGGCGGTACAGGCAGTCGGCAGCACCGAGGACATCGCGCTGTACGTGGAGGTCCAGCAGTTCTACGGGCGCCAGATGCGCTACCTGGACGAGGGCCGCGTGCAGGAGTGGGCCAAGACCTTCACCGAGGACGGGATGTTCGCCGCCAACGCGCACCCCGAACCCGCCCGCGGCCGGACGGCCATCGAGGCCGGCGCGCTCGAAGCGGCCACCCGCCTGGCGGAACAGGGCATCCAGCGGCGGCACTGGCTGGGCATGGTGCAGGTCGATCCGCAGCCCGACGGCAGCATCGTGGCCAAGAGCTACGCGGTGATCATCGGTACGCCGCTGGGTGGCAAGGCTGCGGTCGACCTCAGCTGTGACTGCGTGGACGTGCTGGTGCGCGAGGGCGGCGCGCTCCTGGTGCGCGAGCGCCAGGTGTACCGCGACGACCTGCCGAGGAACTGA	MSQAVQAVGSTEDIALYVEVQQFYGRQMRYLDEGRVQEWAKTFTEDGMFAANAHPEPARGRTAIEAGALEAATRLAEQGIQRRHWLGMVQVDPQPDGSIVAKSYAVIIGTPLGGKAAVDLSCDCVDVLVREGGALLVRERQVYRDDLPRN	MHPDLLPHLRCPVCGQPLHQADAAPPRALRCPAGHSFDIARQGYVNLLTGRAPHVGDTAEMIAAREEFLAAGHYDPFSAALATAAARAVPRRVRPGDGVGEPVAYPDLVVDAGAGTGRHLAAVLDAVPTAVGLALDVSKPALRRAARAHPRAGAAVCDTWGRLPLADATVAVLVNVFAPRNGPEFRRVLRPDGALLVVTPTAEHLVELVDRLGLLRVDPAKDARVADSLTRHFEPAGQSTHRHRLQLTRKEVLTLVGMGPSAWHTDPARLTARVAALSEPVTVTAAVRLARYRPI	50.85	gnl|BL_ORD_ID|137|hsp_num:0	158			576	675	tylosin; mycinamicin
BGC0000208.1|Chelocardin_21 # 19793 # 20581 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.688	BGC0000208.1|Chelocardin_21 	19793	20581	+	Loose	450	36.1946	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	20.38	3004045	protein variant model	F203A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGAGGAGCACCGAGGAGCCGCGGGTCGCCTTGGTCACGGGAGCGACCAGCGGGATCGGTCTCGCCGTCACCAAGGCGCTGGCCGCCAGGGGACTGCGGGTGTTCATCTGCGCGCGCAACCGGGAGAACGTCGTTTCCACGGTGAAGGAGTTGCGGGCGCAGGGTTTGGACGTGGACGGCCAGGCCGGTGACGTGCGGTCGGTGGCCGCCGTTCGCGAGGTGGTCGAGTCCGCGGTCAACCGGTTCGGCACCATCAGCGTGCTGGTCAACAACGCCGGCCGCAGCGGGGGCGGGATCACCGCGAAGATCACCGACGAGCTGTGGCAGGACGTGATCGACACCAATCTCAACAGCGTCTTCACGGTCACCCGCGAGGTGCTGACCACCGGCGGGCTCGACGGGGCCGACGGCGGCCGGATCATCAACATCGCCTCGACCGGGGGCAAGCAGGGCGTCCCGCTCGGCGCGCCCTACTCGGCGGCCAAGAGCGGGGTCATCGGCTTCACCAAGGCGCTGGGCAAGGAACTGGCCAAGACCGGGGTCACGGTGAACGCCGTCTGCCCCGGCTACGTCGAAACGCCGATGGCCGTCCGCGTCCGGCAGGCGTATGCCAGCACTTGGGACACCACCGACGAAAACGTGCTGGCGCGGTTCAACGACAAGATCCCGCTCGGCCGCTACTGCACTCCGGAAGAGGTGGCGGGCATGGTCGACTACCTGGTCGCCGACACGGCCGCTTCGGTGACGGCGCAGGCGATCAACGTCTGCGGCGGCCTCGGCAACTACTGA	MRSTEEPRVALVTGATSGIGLAVTKALAARGLRVFICARNRENVVSTVKELRAQGLDVDGQAGDVRSVAAVREVVESAVNRFGTISVLVNNAGRSGGGITAKITDELWQDVIDTNLNSVFTVTREVLTTGGLDGADGGRIINIASTGGKQGVPLGAPYSAAKSGVIGFTKALGKELAKTGVTVNAVCPGYVETPMAVRVRQAYASTWDTTDENVLARFNDKIPLGRYCTPEEVAGMVDYLVADTAASVTAQAINVCGGLGNY	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	100.00	gnl|BL_ORD_ID|4712|hsp_num:0	2666			27	753	triclosan
BGC0000208.1|Chelocardin_22 # 20610 # 21557 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.678	BGC0000208.1|Chelocardin_22 	20610	21557	+	Loose	500	26.9498	PFM-2	30.23	3006966	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	PFM beta-lactamase	ATGCCCGCCGCAGCACAGCAGCACACCGAACACCGGATCGACATCGACGCTCCCGCCGGCCTGGTGTACCGCATCATCGCGGACGCGACCGAGTGGCCGCGGCACTTCACCCCGACCGTCCACGTTGATCAGTCCGAACTGGACGGACACACCGAACGCCTGCACATCTGGGCCAACGCCAACGGGCAGCTGAAGAGCTGGACCTCGCTCCGGGAACTCGACGAGCGGGCCGGCCGGATCCGGTTCCGGCAGGAGGTGTCCGCGCCCCCGGTCGCCTCGATGAGCGGCGAGTGGATCGTGTCCGAGCGGGTCGCGGAGCGCACCACGCTGGTGCTGACGCACGACTTCGCCGCGGTGGACGACGATCCCGCCGGAGTGGAATGGATCACCAAGGCCACCAACGGGAACAGTGACACCGAACTGGCGAACATCAAGGCACTGGCCGAGCGCTGGGAGCGGATGGACCGGCTGGCCTTCGACTTCGAGGACTCCGTGCTGGTACGGGCGCCCAAGGAACGGGCGTACCACTTCCTGGACCGCGTGGACCTGTGGCCGGACCGGCTGCCCCACGTCGCCAGGCTGGAGCTGCGCGAGGACGTGCCCGGAGTTCAGCACATGTCCATGGACACCAAGGCGAAGGACGGATCGACGCACACCACGGTGTCGGTGCGGGTGTGCTTCCCCGAAGCCCGGATCGTCTACAAGCAACTCGTGCCGCCCGCGTTGCTGACCACCCACACCGGAGTGTGGACGTTCGAGGACACAGCGGACGGTGTTTTGGTGACTTCCGCGCACACGGTCGTGCTCAACGAGGCCAACATCGGCACGGTGCCCGGCCCGGCCGCGACTGTCGAGTCGACGCGCGACTTCGTCCGCAACGCGATCAGCGGCAACAGCCAGGCCACGCTGCGTCATGCCAAGGCGTTCGCCGAGGCGACCGATGCCTGA	MPAAAQQHTEHRIDIDAPAGLVYRIIADATEWPRHFTPTVHVDQSELDGHTERLHIWANANGQLKSWTSLRELDERAGRIRFRQEVSAPPVASMSGEWIVSERVAERTTLVLTHDFAAVDDDPAGVEWITKATNGNSDTELANIKALAERWERMDRLAFDFEDSVLVRAPKERAYHFLDRVDLWPDRLPHVARLELREDVPGVQHMSMDTKAKDGSTHTTVSVRVCFPEARIVYKQLVPPALLTTHTGVWTFEDTADGVLVTSAHTVVLNEANIGTVPGPAATVESTRDFVRNAISGNSQATLRHAKAFAEATDA	MKLINILSAISLACITSQVFANQSDLTLIHFKGPLYIVEDKEYVQENSMVYIGEQHITVIGATWTPATAEKLEQEIRKISPLPIKEVINTNYHTDRAGGNAYWRKLGASIVSTQMTYDLEKSQWRSIVDFTRQGMEHYPVLEQSLPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFPEERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLISSGELPVEAIIAGHNSPIQSVELIDHYLNLLEHGEQ	124.51	gnl|BL_ORD_ID|4553|hsp_num:0	5623			498	615	
BGC0000208.1|Chelocardin_23 # 21493 # 21795 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000208.1|Chelocardin_23 	21493	21795	-	Loose	496	23.0978	IMP-68	28.57	3005019	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGCAGTGTGAAGTGCTCGACCCGCCGGCCCCGCGGCAGCAGCTCGCCGAGCAGCCCCATCTGGTGCCAGATCTCCAACGTGCGGGCGTGCGTCGCGAGCGCACGACTCGTCGTGGCCGGGCCGGCGCTACGGTCCACCAGCCGTACCCGCACCCCTCGGCGGGCCAGCTCGTGCGCGGCGGTCAGCCCGACCGGCCCCGCCCCGGCCACGAGGACTTCGGGCTCTTCGCCGGAGTCCTCAGGCATCGGTCGCCTCGGCGAACGCCTTGGCATGACGCAGCGTGGCCTGGCTGTTGCCGCTGA	MQCEVLDPPAPRQQLAEQPHLVPDLQRAGVRRERTTRRGRAGATVHQPYPHPSAGQLVRGGQPDRPRPGHEDFGLFAGVLRHRSPRRTPWHDAAWPGCCR	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPGHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	40.82	gnl|BL_ORD_ID|2751|hsp_num:0	3762			573	657	
BGC0000208.1|Chelocardin_28 # 23376 # 24557 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.740	BGC0000208.1|Chelocardin_28 	23376	24557	+	Loose	700	28.1054	tet(X4)	31.11	3004720	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGAAGACGGTCGCGATCGTCGGCGCTTCGCTGGCCGGCGCCCGTACCGCCCAGGAACTGCGGGCACAGGGTTTCGACGGCCGGGTGGTCCTCATCGGCGAAGAGCCGCATCTCCCCTACGACCGGCCACCGCTGTCCAAGGCTTTTCTTGCCGGCACTGCTTCGCGGGAGTCTCTGGAGCTACTCGACAGCGACGATCTCGGCGCACTGGAGCTACGGCTCGGCACGCGCGCCGAACGTCTCGACGCGGCCGCGGGCCGGCTGGTCCTGTCCGATGGCGAAATCGCTGCGGACGGGATCGTGGTCGCGACCGGTGGGCGCGCCCGGAGGTTGCCCGGCACCGAGTCCGTCCGCGGAGTGCACGTGCTGCGCACCCTCGACGACGCATCGGCGCTGCGGGAGGAGCTGGTGCCGGGCGTGCAGGTGGTGGTCGTCGGGGGCGGGTTCATCGGCGCGGAAGTCGCGTCGACGTGCCGCACGCTCGGGCTCGACGTGACCGTTCTCGAAGCGCTCGAAACCCCGCTGGTCCGGGTGCTCGGACCGCAGCTGGCGCAAGCCTGCGCGCGGCTGCACGAGCGGCACGGCACGACCTTGCGCTGCCACGCCGCCGTCGACGGGCTCGACACGCGCGCGGACGGAGCCGGACGCCGGGTGACCGGCGTCCGGCTCGCCTCCGGCGGGACCCTCCCGGCCGACGTCGTCGTCACCGGGATCGGCATGGTGCCCGCCACGGAGTGGCTTTCCGGCTCCGGCCTCGCGGCCGCCGGCGGCGTGCCCACCTCCGCCGGGCTGGTCACCGAGCTGCCGAACGTGGTCGCGGTCGGCGACGTCGCCGCCTGCGCCTCGGCCGAGACCGGGCGCCCGCAACGGCACGAACACTGGACCAACGCCAGTGAGCAGGCCCCGGTGGCGGTGGCGAACCTGCTGGCCGGACACCTCGTGCGCGAGTACCGGCCGAGCGGTTACGTATGGTCCGACCAGTACTCGGGCACCCTCCAGCTGGCCGGTCACCCCGAGCCGGGCGACGAGCTGGTGGTCACCGAGGGCACCGCGAGCGACGAAGCCTTCGCCGCGACCTTCCGGCGCGACGGCCGCACCACCGCGGTGTTCGCGCTGAACCTGCCCCGCGCCTTCACCCGGTTGCGGCGCCAGGCCTTCCGCCGCCCGGCGCCGGTCGCCTGA	MKTVAIVGASLAGARTAQELRAQGFDGRVVLIGEEPHLPYDRPPLSKAFLAGTASRESLELLDSDDLGALELRLGTRAERLDAAAGRLVLSDGEIAADGIVVATGGRARRLPGTESVRGVHVLRTLDDASALREELVPGVQVVVVGGGFIGAEVASTCRTLGLDVTVLEALETPLVRVLGPQLAQACARLHERHGTTLRCHAAVDGLDTRADGAGRRVTGVRLASGGTLPADVVVTGIGMVPATEWLSGSGLAAAGGVPTSAGLVTELPNVVAVGDVAACASAETGRPQRHEHWTNASEQAPVAVANLLAGHLVREYRPSGYVWSDQYSGTLQLAGHPEPGDELVVTEGTASDEAFAATFRRDGRTTAVFALNLPRAFTRLRRQAFRRPAPVA	MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	102.08	gnl|BL_ORD_ID|2277|hsp_num:0	3402			27	162	tigecycline; tetracycline
BGC0000208.1|Chelocardin_29 # 24585 # 25031 # -1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.702	BGC0000208.1|Chelocardin_29 	24585	25031	-	Loose	530	26.1794	OXA-899	25.0	3005093	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGAGAGACCGGAAGATCACCGCGGTACTGGCGGCGGCGGTCGCGACGGTGGCCGCGGCCGCGACGATCGGGTTCGCGGGCACGGCCGAGGCGGCCGGTGCGCCGTGCAGCGCGCGGGCCAAGGCGTGCGTGAAGCTGTCGGCGAACAAGGCGTGGCTGATGAAGGGCGGGAAGGTGGTCCGCGGCGCGGTCCCGGTGACCGTCGGGCGGCCGGGGCACCTGACCCCGGAAGGGTCCTTCACCGTGCAGTGGAAGGATCTTCACCACCACAGCAAGGAGTACAACGCGCCGATGCCGTACTCGGTGTTCTTCACCACCACCGGTGTCGCGTTCCACGAGGGCAGCCTGAACGTCCAGTCGCACGGCTGCGTGCACCTCTCGCACGAGGACGCGGTGGCCTTCTTCGACTACCTGCGCCCGAGCGACGTCGTGGAGGTCGTGCGCTGA	MRDRKITAVLAAAVATVAAAATIGFAGTAEAAGAPCSARAKACVKLSANKAWLMKGGKVVRGAVPVTVGRPGHLTPEGSFTVQWKDLHHHSKEYNAPMPYSVFFTTTGVAFHEGSLNVQSHGCVHLSHEDAVAFFDYLRPSDVVEVVR	MMKRRHAATGALLAALATFAHAEHPICTIVADGATGKAVLQEGRCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGFMRRIVNRQLPVSARTYEMVDRTVQTWQVPGGWSVHGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALLARLPEVLAFAGQ	53.82	gnl|BL_ORD_ID|2809|hsp_num:0	3826			465	654	cloxacillin; oxacillin; cefalotin
BGC0000208.1|Chelocardin_30 # 25202 # 25630 # 1 # ID=1_30;partial=01;start_type=GTG;rbs_motif=GGA;rbs_spacer=15bp;gc_cont=0.730	BGC0000208.1|Chelocardin_30 	25202	25630	+	Loose	500	24.6386	ErmH	45.16	3002823	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGGTGGCAGACCTCCTCCCCCGTGACCCCGAGCCCGCCGGAATCGGACCGGGACCGCACGAGCGGCCCGATCCCGGCGGCGCGAACGCACCCGGCGAAAGCGGCGGGGACGGCCGGAACCGGAAGCGGGCCAAGCGGAAACGCCCGTTCTGGCAGGAGCTGCTCATCCTGGTCGGCGCGGCGCTCGTGCTCACCGTCCTGGTCCAGCAGTTCGTGGCGAAGGTGTTCCTGATCCCGTCCTCCTCGATGGAGGCGACCCTGCACGGGTGCAACGGCTGTTTCGGGGACCGGGTCCTGGTCGACCGGATCACCTACGACTTCACCGATCCCGAGCCGGGCGACGTGGTGGTGTTCCGCGGGCCGCGGTCGTGGACCTCGGCCGAGTCCGCCCCGCGGCCCTCGCCCGGGTTCCTCGCCGGGCTCGGGCAG	MVADLLPRDPEPAGIGPGPHERPDPGGANAPGESGGDGRNRKRAKRKRPFWQELLILVGAALVLTVLVQQFVAKVFLIPSSSMEATLHGCNGCFGDRVLVDRITYDFTDPEPGDVVVFRGPRSWTSAESAPRPSPGFLAGLGQ	MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR	47.83	gnl|BL_ORD_ID|1100|hsp_num:0	1193			150	237	erythromycin; lincomycin; pristinamycin IC; oleandomycin; carbomycin
